Health food with auxiliary blood sugar and blood lipid lowering functions

Abstract

The invention relates to a health food with auxiliary blood sugar and blood lipid lowering functions. The health food is characterized in that: each 1000 granules of capsules comprise 90-110g of purified konjak powder, 72-88g of extracts from acanthopanax, 54-66g of extracts from gynostemma pentaphylla, and 54-66g of extracts from green tea. The weight of contents in each granule of the capsule is 0.3g, and each 100g of the contents comprises 33.67-40.33g of glucomannan, 10.01-11.99g of tea polyphenol, and 3.01-3.59g of total saponins. The health food which is an oral capsule preparation and has the advantages of accurate efficacy, rapid action, safety and reliability, and small taking dosage is convenient for carrying and long-term taking; and the health food which simultaneously has dual auxiliary blood sugar and blood lipid lowering functions is helpful for rehabilitation of patients who only have hyperglycemia or hyperlipidemia, or simultaneously have hyperglycemia and hyperlipidemia, and also allows concurrent cardiovascular and cerebrovascular diseases and the like of diabetes and hyperlipidemia to be prevented. The health food of the invention is different from simple blood sugar and blood lipid products in the recent market.

Description

technical field [0001] The invention relates to a formula composition of a health food, in particular to a health food that can assist in lowering blood sugar and blood fat. Background technique [0002] At present, my country's hypoglycemic drugs are mainly western medicines, accounting for about 70% of the entire market share, supplemented by Chinese patent medicines, accounting for more than 20%. Although chemical hypoglycemic prescription drugs have obvious effects, the drug resistance, drug resistance, and liver damage caused by long-term medication will make diabetic patients feel more painful. Among the world's best-selling drugs in 2002, 8 were lipid-lowering products; the world's first and second sales were all lipid-lowering drugs, which were Pfizer's LiPitoR (atorvastatin) and Merck's ZoCoR (octane). Vastatin). Although the lipid-lowering effects of these two drugs are obvious, they have certain side effects. [0003] At present, the hypoglycemic and lipid-lowe...

AI Technical Summary

Problems solved by technology

Although the lipid-lowering effects of these two drugs are obvious, they have certain side effects.

[0003] At present, the hypoglycemic and lipid-lowering products on the market are mainly divided into two parts, one is drugs with hypoglycemic and lipid-lowering effects, such as Xuezhikang, Zocorzhi, Compound Danshen Tablets, etc.; Fatty health products, such as Fengling Capsules, Tangdingkang Tablets, Kanglishu Capsules, Spirulina, Lecithin, Fish Oil, Nuokang Capsules, Danshenzhikang Capsules, Antong Capsules, Guiling Capsules, Shenqi Capsules, Zhirui Tablets , soybean phospholipid soft capsules, but these products are still far from meeting the needs of people with high blood sugar and high blood lipids, and they also lack competitiveness

Images